These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33715138)

  • 1. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19.
    Rabeea SA; Merchant HA; Khan MU; Kow CS; Hasan SS
    Daru; 2021 Jun; 29(1):217-221. PubMed ID: 33715138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010.
    Ilyas S; Moncrieff J
    Br J Psychiatry; 2012 May; 200(5):393-8. PubMed ID: 22442100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant Prescribing in England: Patterns and Costs.
    Heald AH; Stedman M; Davies M; Livingston M; Taylor D; Gadsby R
    Prim Care Companion CNS Disord; 2020 Apr; 22(2):. PubMed ID: 32302071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.
    Murray ML; Thompson M; Santosh PJ; Wong IC
    Drug Saf; 2005; 28(12):1151-7. PubMed ID: 16329717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased use of antidepressants in Canada: 1981-2000.
    Hemels ME; Koren G; Einarson TR
    Ann Pharmacother; 2002 Sep; 36(9):1375-9. PubMed ID: 12196054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter retrospective study of antidepressant use in outpatient clinics in China pre- and post-COVID.
    Zhao M; Chang L; Yu J; Wang J; Song Y; Su S; Chen C; Lun Y; Cheng F; Zhao Y; Zhou C
    Int J Clin Pharm; 2024 Oct; 46(5):1215-1224. PubMed ID: 39141181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach.
    Estrela M; Silva TM; Gomes ER; Piñeiro M; Figueiras A; Roque F; Herdeiro MT
    J Epidemiol Community Health; 2022 Apr; 76(4):335-340. PubMed ID: 34625519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of antidepressant prescribing trends in England 2015-2019.
    Lalji HM; McGrogan A; Bailey SJ
    J Affect Disord Rep; 2021 Dec; 6():100205. PubMed ID: 34957433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs.
    Bradlow J; Coulter A
    BMJ; 1993 Nov; 307(6913):1186-9. PubMed ID: 8251847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal Variation in Antidepressant Prescribing: Year on Year Analysis for England.
    Heald A; Stedman M; Farman S; Ruzhdi N; Davies M; Taylor D
    Prim Care Companion CNS Disord; 2021 Apr; 23(2):. PubMed ID: 34000164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in incident diagnoses and drug prescriptions for anxiety and depression during the COVID-19 pandemic: an 18-month follow-up study based on the UK Biobank.
    Wang Y; Ge F; Wang J; Yang H; Han X; Ying Z; Hu Y; Sun Y; Qu Y; Aspelund T; Hauksdóttir A; Zoega H; Fang F; Valdimarsdóttir UA; Song H
    Transl Psychiatry; 2023 Jan; 13(1):12. PubMed ID: 36653375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications.
    Davies J; Cooper RE; Moncrieff J; Montagu L; Rae T; Parhi M
    Addict Behav; 2022 Feb; 125():107143. PubMed ID: 34674906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada.
    Uthayakumar S; Tadrous M; Vigod SN; Kitchen SA; Gomes T
    Depress Anxiety; 2022 Feb; 39(2):156-162. PubMed ID: 34843627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant drug prescription and incidence of COVID-19 in mental health outpatients: a retrospective cohort study.
    Glebov OO; Mueller C; Stewart R; Aarsland D; Perera G
    BMC Med; 2023 Jun; 21(1):209. PubMed ID: 37340474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of primary care prescription trends in England during the COVID-19 pandemic compared against a predictive model.
    Frazer JS; Frazer GR
    Fam Med Community Health; 2021 Aug; 9(3):. PubMed ID: 34344766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunity cost of antidepressant prescribing in England: analysis of routine data.
    Hollinghurst S; Kessler D; Peters TJ; Gunnell D
    BMJ; 2005 Apr; 330(7498):999-1000. PubMed ID: 15778232
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019-2023.
    Knight KJ; Fordham RJ; Crabtree NJ; Knapp KM
    Osteoporos Int; 2024 Aug; 35(8):1451-1460. PubMed ID: 38795142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.